References
- Jacquet Y. F., Abrams G. M. Postural asymmetry and movement disorder after unilateral microinjection of ACTH (1–24) in rat brainstem. Science 1982; 218: 175–177
- Jacquet Y. F. “Dystonia”-like postural asymmetry after microinjection of ACTH N-terminal fragments but not after ACTH139 in rat brainstem suggests a role of neuropetide mutation in genetic movement disorder. Brain Research 1984; 294: 144–147
- Kastin A. J., Kullander S., Borglin N. E., Dahlberg B., Dyster-Aas K., Krakau C. E.T.Lingvar D. H., Miller M. C., Bowers C. Y., Schally A. V. Extrapigmentary effects of melanocyte-stimulat-ing hormone in amenorrhoeic women. Lancet 1968; 1: 1007–1010
- Marsden C D., Jenner P. The pathophysiology of extrapyramidal side-effects of neuroleptic drugs. Psychological Medicine 1980; 10: 55–72
- O'Donohue T. L., Dorsa D. M. The opiomelanotrophinergic neuronal and endocrine systems. Peptides 1982; 3: 353–395
- Salzman C. Clinical geriatric psychopharmacology. McGraw-Hill, New York 1984
- Sandyk R. ACTH and the effects of anticholinergic drugs in dystonia. International Journal of Neuroscience 1989; 45: 123–126
- Sandyk R. Melanocyte-stimulating hormone in tardive dyskinesia. Biological Psychiatry, in press
- Sandyk R., Kay S. R. Acute drug-induced dystonia and negative symptoms of schizophrenia. International Journal of Neuroscience, in press
- Sandyk R., Kay S. R., Decina P. The relationship of drug-induced dystonic movements to abnormal hypothamic-pituitary regulation of melanocyte-stimulating hormone. Functional Neurology 1989, (submitted for publication)
- Shuster S., Thody A. J., Plummer N., Goolamali S. K., Bates D. Melanocyte stimulating hormone and parkinsonism. Lancet 1973; 1: 463–465
- Sweet C. Drug-induced dystonia. American Journal of Psychiatry 1975; 132: 532–534
- Thody A. J. The significance of melanocyte stimulating hormone (MSH) and the control of its secretion in the mammal. Advance in Drug Research, A. J. Harper, A. B. Simmonds. Academic Press, London 1974; 23–74